EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Volume 207 / Numéro 4 (2013) Biologie Aujourd'hui, 207 4 (2013) 249-259 Références
Accès gratuit
Numéro
Biologie Aujourd'hui
Volume 207, Numéro 4, 2013
Page(s) 249 - 259
DOI https://doi.org/10.1051/jbio/2013025
Publié en ligne 5 mars 2014
  • Alting A.C., Meijer R.J., van Beresteijn E.C., Incomplete elimination of the ABBOS epitope of bovine serum albumin under simulated gastrointestinal conditions of infants. Diabetes Care, 1997, 20, 875–880. [CrossRef] [PubMed] [Google Scholar]
  • Beck L.H. Jr., Bonegio R.G., Lambeau G., Beck D.M., Powell D.W., Cummins T.D., Klein J.B., Salant D.J., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med, 2009, 361, 11–21. [CrossRef] [PubMed] [Google Scholar]
  • Beck L.H. Jr., Fervenza F.C., Beck D.M., Bonegio R.G., Malik F.A., Erickson S.B., Cosio F.G., Cattran D.C., Salant D.J., Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol, 2011, 22, 1543−1550. [CrossRef] [PubMed] [Google Scholar]
  • Berthoux F.C., Berthoux P., Hassan A.A., Vacherot C., Pomier G., Laurent B., Le Petit J.C., [Immunogenetics of primary membranous glomerulonephritis]. Presse Med, 1990, 19, 990–993. [PubMed] [Google Scholar]
  • Coenen M.J., Hofstra J.M., Debiec H., Stanescu H.C., Medlar A.J., Stengel B., Boland-Augé A., Groothuismink J.M., Bockenhauer D., Powis S.H., Mathieson P.W., Brenchley P.E., Kleta R., Wetzels J.F., Ronco P., Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrology, 2013, 24, 677–683. [CrossRef] [Google Scholar]
  • Dähnrich C., Komorowski L., Probst C., Seitz-Polski B., Esnault V., Wetzels J.F., Hofstra J.M., Hoxha E., Stahl R.A., Lambeau G., Stöcker W., Schlumberger W., Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta, 2013, 421, 213–218. [CrossRef] [PubMed] [Google Scholar]
  • Debiec H., Ronco P., Nephrotic syndrome : A new specific test for idiopathic membranous nephropathy. Nat Rev Nephrology, 2011a, 7, 496–498. [Google Scholar]
  • Debiec H., Ronco P., PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. New Engl J Med, 2011b, 364, 689–690. [Google Scholar]
  • Debiec H., Guigonis V., Mougenot B., Decobert F., Haymann J.P., Bensman A., Deschênes G., Ronco P.M., Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med, 2002, 346, 2053–2060. [CrossRef] [PubMed] [Google Scholar]
  • Debiec H., Nauta J., Coulet F., van der Burg M., Guigonis V., Schurmans T., de Heer E., Soubrier F., Janssen F., Ronco P., Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet, 2004, 364, 1252–1259. [CrossRef] [PubMed] [Google Scholar]
  • Debiec H., Martin L., Jouanneau C., Dautin G., Mesnard L., Rondeau E., Mousson C., Ronco P., Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. Am J Transplant, 2011a, 11, 2144–2152. [CrossRef] [PubMed] [Google Scholar]
  • Debiec H., Lefeu F., Kemper M.J., Niaudet P., Deschênes G., Remuzzi G., Ulinski T., Ronco P., Early childhood membranous nephropathy due to cationic bovine serum albumin. New Engl J Med, 2011b, 364, 2101–2110. [CrossRef] [Google Scholar]
  • Debiec H., Hanoy M., François A., Guerrot D., Ferlicot S., Johanet C., Aucouturier P., Godin M., Ronco P., Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrology, 2012, 23, 1949–1954. [CrossRef] [Google Scholar]
  • Glassock R.J., Diagnosis and natural course of membranous nephropathy. Semin Nephrol, 2003, 23, 324–332. [CrossRef] [PubMed] [Google Scholar]
  • Hofstra J.M., Beck L.H. Jr., Beck D.M., Wetzels J.F., Salant D.J., Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrology, 2011, 6, 1286–1291. [CrossRef] [PubMed] [Google Scholar]
  • Hofstra J.M., Debiec H., Short C.D., Pellé T., Kleta R., Mathieson P.W., Ronco P., Brenchley P.E., Wetzels J.F., Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrology, 2012, 23, 1735–1743. [CrossRef] [PubMed] [Google Scholar]
  • Hoxha E., Kneißler U., Stege G., Zahner G., Thiele I., Panzer U., Harendza S., Helmchen U.M., Stahl R.A., Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int, 2012, 82, 797–804. [CrossRef] [PubMed] [Google Scholar]
  • Husby S., Normal immune responses to ingested foods. J Pediatr Gastroenterol Nutr, 2000, 30, 13–19. [CrossRef] [Google Scholar]
  • Kanigicherla D., Gummadova J., McKenzie E.A., Roberts S.A., Harris S., Nikam M., Poulton K., McWilliam L., Short C.D., Venning M., Brenchley P.E., Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int, 2013, 83, 940–948. [CrossRef] [PubMed] [Google Scholar]
  • Kerjaschki D., Farquhar M.G., The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA, 1982, 79, 5557–5561. [CrossRef] [Google Scholar]
  • Kerjaschki D., Farquhar M.G., Immunocytochemical localization of the Heymann nephritis antigen (gp330) in glomerular epithelial cells of normal Lewis rats. J Exp Med, 1983, 157, 667–686. [CrossRef] [PubMed] [Google Scholar]
  • Kletter B., Gery I., Freier S., Davies A.M., Immune responses of normal infants to cow milk. I. Antibody type and kinetics of production. Int Arch Allergy Appl Immunol, 1971, 40, 656–666. [CrossRef] [PubMed] [Google Scholar]
  • Klouda P.T., Manos J., Acheson E.J., Dyer P.A., Goldby F.S., Harris R., Lawler W., Mallick N.P., Williams G., Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet, 1979, 2, 770–771. [CrossRef] [PubMed] [Google Scholar]
  • Knehtl M., Debiec H., Kamgang P., Callard P., Cadranel J., Ronco P., Boffa J.J., A case of phospholipase A(2) receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis, 2010, 57, 140–143. [CrossRef] [PubMed] [Google Scholar]
  • Kuroki A., Iyoda M., Shibata T., Sugisaki T., Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int, 2005, 68, 302–310. [CrossRef] [PubMed] [Google Scholar]
  • Mogues T., Li J., Coburn J., Kuter D.J., IgG antibodies against bovine serum albumin in humans –their prevalence and response to exposure to bovine serum albumin. J Immunol Methods, 2005, 300, 1–11. [CrossRef] [PubMed] [Google Scholar]
  • Murtas C., Allegri L., Ghiggeri G.M., Circulating antipodocyte antibodies in membranous nephropathy : new findings. Am J Kidney Dis, 2013, 62, 12–15. [CrossRef] [PubMed] [Google Scholar]
  • Nortier J.L., Debiec H., Tournay Y., Mougenot B., Noël J.C., Deschodt-Lanckman M.M., Janssen F., Ronco P., Neonatal disease in neutral endopeptidase alloimmunization : lessons for immunological monitoring. Pediatr Nephrol, 2006, 1, 1399–1405. [CrossRef] [Google Scholar]
  • Ogahara S., Naito S., Abe K., Michinaga I., Arakawa K., Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int, 1992, 41, 175–182. [CrossRef] [PubMed] [Google Scholar]
  • Oh Y.J., Yang S.H., Kim D.K., Kang S.W., Kim Y.S., Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One, 2013, 8, e62151. [CrossRef] [PubMed] [Google Scholar]
  • Pérez-Maceda B., López-Bote J.P., Langa C., Bernabeu C., Antibodies to dietary antigens in rheumatoid arthritis –possible molecular mimicry mechanism. Clin Chim Acta, 1991, 203, 153–165. [CrossRef] [PubMed] [Google Scholar]
  • Polanco N., Gutiérrez E., Covarsí A., Ariza F., Carreño A., Vigil A., Baltar J., Fernández-Fresnedo G., Martín C., Pons S., Lorenzo D., Bernis C., Arrizabalaga P., Fernández-Juárez G., Barrio V., Sierra M., Castellanos I., Espinosa M., Rivera F., Oliet A., Fernández-Vega F., Praga M., Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología., Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol, 2010, 21, 697–704. [CrossRef] [PubMed] [Google Scholar]
  • Prabakaran T., Nielsen R., Larsen J.V., Sørensen S.S., Feldt-Rasmussen U., Saleem M.A., Petersen C.M., Verroust P.J., Christensen E.I., Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease. PLoS One, 2011, 6, e25065. [CrossRef] [PubMed] [Google Scholar]
  • Qin W., Beck L.H. Jr., Zeng C., Chen Z., Li S., Zuo K., Salant D.J., Liu Z., Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol, 2011, 22, 1137–1143. [CrossRef] [PubMed] [Google Scholar]
  • Ronco P., [Idiopathic and secondary membranous nephropathies]. Press Med, 2012a, 41, 290. [CrossRef] [Google Scholar]
  • Ronco P., Glomérulopathie extramembraneuse par immunisation materno-fœtale. Bull Acad Natle Med, 2012b, 196, 1507–1508. [Google Scholar]
  • Ronco P., Debiec H., Pathogenesis of membranous nephropathy : recent advances and future challenges. Nat Rev Nephrol, 2012, 8, 203–213. [CrossRef] [PubMed] [Google Scholar]
  • Ronco P., Debiec H., Imai H., Circulating antipodocyte antibodies in membranous nephropathy : Pathophysiologic and clinical relevance. Am J Kidney Dis, 2013, 62, 16–19. [CrossRef] [PubMed] [Google Scholar]
  • Sathe S.K., Teuber S.S., Roux K.H., Effects of food processing on the stability of food allergens. Biotechnol Adv, 2005, 23, 423–429. [CrossRef] [PubMed] [Google Scholar]
  • Schmidt D.G., Meijer R.J., Slangen C.J., van Beresteijn E.C., Raising the pH of the pepsin-catalysed hydrolysis of bovine whey proteins increases the antigenicity of the hydrolysates. Clin Exp Allergy, 1995, 25, 1007−1017. [CrossRef] [PubMed] [Google Scholar]
  • Sreedharan R., Mehta D.I., Gastrointestinal tract. Pediatrics, 2004, 113, 1044–1050. [PubMed] [Google Scholar]
  • Stanescu H.C., Arcos-Burgos M., Medlar A., Bockenhauer D., Kottgen A., Dragomirescu L., Voinescu C., Patel N., Pearce K., Hubank M., Stephens H.A., Laundy V., Padmanabhan S., Zawadzka A., Hofstra J.M., Coenen M.J., den Heijer M., Kiemeney L.A., Bacq-Daian D., Stengel B., Powis S.H., Brenchley P., Feehally J., Rees A.J., Debiec H., Wetzels J.F., Ronco P., Mathieson P.W., Kleta R., Risk HLA-DQA1 and PLA2R1 alleles and idiopathic membranous nephropathy. New Engl J Med, 2011, 364, 616–626 [Google Scholar]
  • Svobodova B., Honsova E., Ronco P., Tesar V., Debiec H., Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant, 2013, 28, 1839–1844 [CrossRef] [PubMed] [Google Scholar]
  • Torente F., Murch S. Food allergic enteropathy., In : Walker A.W., Goulet O., Kleinman R.E. (Eds), Pediatric gastrointestinal disease. 2004, 4th ed. Hamilton, ON, Canada : BC Decker, pp. 944–958. [Google Scholar]
  • Van Damme B.J., Fleuren G.J., Bakker W.W., Vernier R.L., Hoedemaeker P.J., Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest, 1978, 38, 502–510. [PubMed] [Google Scholar]
  • Vaughan R.W., Demaine A.G., Welsh K.I., A DQA1 allele is strongly associated with idiopathic membranous nephropathy. Tissue Antigens, 1989, 34, 261–269. [CrossRef] [PubMed] [Google Scholar]
  • Waldman M., Austin H.A. 3rd, Controversies in the treatment of idiopathic membranous nephropathy. Nat Rev Nephrol, 2009, 5, 469–479. [CrossRef] [PubMed] [Google Scholar]
  • Winer S., Astsaturov I., Cheung R.K., Schrade K., Gunaratnam L., Wood D.D., Moscarello M.A., O’Connor P., McKerlie C., Becker D.J., Dosch H.M., T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice. J Immunol, 2001, 166, 4751–4756. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.